Enhancement of OX40-induced apoptosis by TNF coactivation in OX40-expressing T cell lines in vitro leading to decreased targets for HIV type 1 production

AIDS Research and Human Retroviruses

Volumn 24, Issue 3, 2008, Pages 423-435

  Takahashi, Yoshiaki ^a,b   Tanaka, Reiko ^a   Yamamoto, Naoki ^b   Tanaka, Yuetsu ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CASPASE 8; CD134 ANTIGEN; FAS LIGAND; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL DEATH; CELL FATE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; ANNEXIN A5; APOPTOSIS; CASPASE 3; CASPASE 8; CELL LINE; CELL SURVIVAL; HIV CORE PROTEIN P24; HIV-1; HUMANS; MICE; RECEPTORS, OX40; RECEPTORS, TUMOR NECROSIS FACTOR; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 41449093302     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2007.0092     Document Type: Article

References (58)

1. Latza U, Durkop H, Schnittger S, et al.: The human OX40 homolog: cDNA structure, expression and chromosomal assignment of the ACT35 antigen. Eur J Immunol 1994;24:677-683.
2. Mallett S, Fossum S, and Barclay AN: Characterization of the MRC OX40 antigen of activated CD4 positive T lymphocytes: A molecule related to nerve growth factor receptor. EMBO J 1990;9:1063-1068.
3. Baker SJ and Reddy EP: Modulation of life and death by the TNF receptor superfamily. Oncogene 1998;17:3261-3270.
4. Tanaka Y, Inoi T, Tozawa H, Yamamoto N, and Hinuma Y: A glycoprotein antigen detected with new monoclonal antibodies on the surface of human lymphocytes infected with human T-cell leukemia virus type-I (HTLV-I). Int J Cancer 1985;36:549-555.
5. Miura S, Ohtani K, Numata N, et al.: Molecular cloning and characterization of a novel glycoprotein, gp34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax. Mol Cell Biol 1991;11:1313-1325.
6. Baum PR, Gayle RB 3rd, Ramsdell F, et al.: Molecular characterization of murine and human OX40/OX40 ligand systems: Identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J 1994;13:3992-4001.
7. Ohshima Y, Tanaka Y, Tozawa H, Takahashi Y, Maliszewski C, and Delespesse G: Expression and function of OX40 ligand on human dendritic cells. J Immunol 1997;159:3838-3848.
8. Stuber E, Neurath M, Calderhead D, Fell HP, and Strober W: Cross-linking of OX40 ligand, a member of the TNF/NGF cytokine family, induces proliferation and differentiation in murine splenic B cells. Immunity 1995;2:507-521.
9. Morimoto S, Kanno Y, Tanaka Y, et al.: CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses. J Immunol 2000;164:4097-4104.
10. Imura A, Hori T, Imada K, et al.: The human OX40/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med 1996;183:2185-2195.
11. Baba E, Takahashi Y, Lichtenfeld J, et al.: Functional CD4 T cells after intercellular molecular transfer of OX40 ligand. J Immunol 2001;167:875-883.
12. Kawamata S, Hori T, Imura A. Takaori-Kondo A, and Uchiyama T: Activation of OX40 signal transduction pathways leads to tumor necrosis factor receptor-associated factor (TRAF) 2- and TRAF5-mediated NF-kappa B activation. J Biol Chem 1998;273:5808-5814.
13. Flynn S, Toellner FM, Raykundalia C, Goodall M, and Lane P: CD4 T cell cytokine differentiation: The B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin 4 and upregulates expression of the chemokine receptor, Blr-1. J Exp Med 1998;188:297-304.
14. Ohshima Y, Yang LP, Uchiyama T, et al.: OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectors. Blood 1998;92:3338-3345.
15. Akiba H, Miyahira Y, Atsuta M, et al.: Critical contribution of OX40 ligand to T helper cell type 2 differentiation in experimental leishmaniasis. J Exp Med 2000;191:375-380.
16. Tanaka H, Demeure CE, Rubio M, Delespesse G, and Sarfati M: Human monocyte-derived dendritic cells induce naive T cell differentiation into T helper cell type 2 (Th2) or Th1/Th2 effectors. Role of stimulator/responder ratio. J Exp Med 2000;192:405-412.
17. Gramaglia I, Jember A, Pippig SD, Weinberg AD, Killeen N, and Croft M: The OX40 costimulatory receptor determines the development of CD4 memory by regulating primary clonal expansion. J Immunol 2000;165:3043-3050.
18. De Smedt T, Smith J, Baum P, Fanslow W, Butz E, and Maliszewski C: OX40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo. J Immunol 2002;168:661-670.
19. Bansal-Pakala P, Jember AJ, and Croft M: Signaling through OX40 (CD134) breaks peripheral T-cell tolerance. Nat Med 2001;7:907-912.
20. Valzasina B, Guiducci C, Dislich H, Killeen N, Weinberg AD, and Colombo MP: Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: A novel regulatory role for OX40 and its comparison with GITR. Blood 2005;105:2845-2851.
21. Imura A, Hori T, Imada K, et al.: OX40 expressed on fresh leukemic cells from adult T-cell leukemia patients mediates cell adhesion to vascular endothelial cells: Implication for the possible involvement of OX40 in leukemic cell infiltration. Blood 1997;89:2951-2958.
22. Brocker T, Gulbranson-Judge A, Flynn S, Riedinger M, Raykundalia C, and Lane P: CD4 T cell traffic control: In vivo evidence that ligation of OX40 on CD4 T cells by OX40-ligand expressed on dendritic cells leads to the accumulation of CD4 T cells in B follicles. Eur J Immunol 1999;29:1610-1616.
23. Aten J, Roos A, Claessen N, Schilder-Tol EJM, Ten Berge IJM, and Weening JJ: Strong and selective glomerular localization of CD134 ligand and TNF receptor-1 in proliferative lupus nephritis. J Am Soc Nephrol 2000;11:1426-1438.
24. Ndhlovu LC, Ishii N, Murata K, Sato T, and Sugamura K: Involvement of OX40 ligand signals in the T cell priming events during experimental autoimmune encephalomyelitis. J Immunol 2001;167:2991-2999.
25. Murata K, Nose M, Ndhlovu LC, Sato T, Sugamura K, and Ishii N: Constitutive OX40/OX40 ligand interaction induces autoimmune-like diseases. J Immunol 2002;169:4628-4636.
26. Jember AG-H, Zuberi R, Liu FT, and Croft M: Development of allergic inflammation in a murine model of asthma is dependent on the costimulatory receptor OX40. J Exp Med 2001;193:387-392.
27. Arestides RS, He H, Westlake RM, et al.: Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation. Eur J Immunol 2002;32:2874-2880.
28. Uchiyama T: Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol 1997;15:15-37.
29. Kopf M, Ruedl C, Schmitz N, et al.: OX40-deficient mice are defective in Th cell proliferation but are competent in generating B cell and CTL responses after virus infection. Immunity 1999;11:699-708.
30. Ekkens MJ, Liu Z, Liu Q, et al.: The role of OX40 ligand interactions in the development of the Th2 response to the gastrointestinal nematode parasite Heligmosomoides polygyrus. J Immunol 2003;170:384-393.
31. Grell M, Zimmermann G, Gottfried E, et al.: Induction of cell death by tumour necrosis factor (TNF) receptor 2, CD40 and CD30: A role for TNF-R1 activation by endogenous membrane-anchored TNF. EMBO J 1999;18:3034-3043.
32. Prasad KV, Ao Z, Yoon Y, et al.: CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci USA 1997;94:6346-6351.
33. Mir SS, Richter BW, and Duckett CS: Differential effects of CD30 activation in anaplastic large cell lymphoma and Hodgkin disease cells. Blood 2000;96:4307-4312.
34. Lee SY, Park CG, and Choi Y: T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J Exp Med 1996;183:669-674.
35. Hess S and Engelmann H: A novel function of CD40: Induction of cell death in transformed cells. J Exp Med 1996;183:159-167.
36. Chan FK and Lenardo MJ: A crucial role for p80 TNF-R2 in amplifying p60 TNF-R1 apoptosis signals in T lymphocytes. Eur J Immunol 2000;30:652-660.
37. Fotin-Mleczek M, Henkler F, Samel D, et al.: Apoptotic crosstalk of TNF receptors: TNF-R2-induces depletion of TRAF2 and IAP proteins and accelerates TNF-R1-dependent activation of caspase-8. J Cell Sci 2002;115:2757-2770.
38. Takahashi Y, Tanaka Y, Yamashita A, Koyanagi Y, Nakamura M, and Yamamoto N: OX40 stimulation by gp34/OX40 ligand enhances productive human immunodeficiency virus type 1 infection. J Virol 2001;75:6748-6757.
39. Biswas P, Smith CA, Goletti D, Hardy EC, Jackson RW, and Fauci AS: Cross-linking of CD30 induces HIV expression in chronically infected T cells. Immunity 1995;2:587-596.
40. Tozawa H, Andoh S, Takayama Y, et al.: Species-dependent antigenicity of the 34-kDa glycoprotein found on the membrane of various primate lymphocytes transformed by human T-cell leukemia virus type-I (HTLV-I) and simian T-cell leukemia virus (STLV-I). Int J Cancer 1988;41:231-238.
41. Tanaka Y, Yoshida A, Tozawa H, Shida H, Nyunoya H, and Shimotohno K: Production of a recombinant human T-cell leukemia virus type-I trans-activator (tax1) antigen and its utilization for generation of monoclonal antibodies against various epitopes on the tax1 antigen. Int J Cancer 1991;48:623-630.
42. Baba M, Miyake H, Okamoto M, Iizawa Y, and Okonogi K: Establishment of a CCR5-expressing T-lymphoblastoid cell line highly susceptible to R5 HIV type 1. AIDS Res Hum Retroviruses 2000;16:935-941.
43. Adachi A, Gendelman HE, Koenig S, et al.: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986;59:284-291.
44. Tanaka R, Yoshida A, Murakami T, et al.: Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection. J Virol 2001;75:11534-11543.
45. + T cells. Hum Immunol 2007;68:563-571.
46. Ohagen A, Ghosh S, He J, et al.: Apoptosis induced by infection of primary brain cultures with diverse human immunodeficiency virus type 1 isolates: Evidence for a role of the envelope. J Virol 1999;73:897-906.
47. Bartz SR and Emerman M: Human immunodeficiency virus type 1 Tat induces apoptosis and increases sensitivity to apoptotic signals by up-regulating FLICE/caspase-8. J Virol 1999;73:1956-1963.
48. Xu X-N, Laffert B, Screaton GR, et al.: Induction of Fas ligand expression by HIV involves the interaction of Nef with the T cell receptor zeta chain. J Exp Med 1999;189:1489-1496.
49. Hrimech M, Yao XJ, Bachand F, Rougeau N, and Cohen EA: Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection. J Virol 1999;73:4101-4109.
50. Casella CR, Rapaport EL, and Finkel TH: Vpu increases susceptibility of human immunodeficiency virus type 1-infected cells to fas killing. J Virol 1999;73:92-100.
51. Lenardo MJ, Angleman SB, Bounkeua V, et al.: Cytopathic killing of peripheral blood CD4 (+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env. J Virol 2002;76:5082-5093.
52. Afford SC, Ahmed-Choudhury J, Randhawa S, et al.: CD40 activation-induced, Fas-dependent apoptosis and NF-kappaB/AP-1 signaling in human intrahepatic biliary epithelial cells. FASEB J 2001;15:2345-2354.
53. Pimentel-Muinos FX and Seed B: Regulated commitment of TNF receptor signaling: A molecular switch for death or activation. Immunity 1999;11:783-793.
54. Holler N, Zaru R, Micheau O, et al.: Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. Nat Immunol 2000;1:489-495.
55. Li X, Yang Y, and Ashwell JD: TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 2002;416:345-347.
56. Blair PJ, Riley JL, Harlan DM, et al.: CD40 ligand (CD154) triggers a short-term CD4(+) T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis. J Exp Med 2000;191:651-660.
57. Rogers PR, Son J, Gramaglia I, Killeen N, and Croft M: OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells. Immunity 2001;15:445-455.
58. Ma BY, Mikolajczak SA, Danesh A, et al.: The expression and the regulatory role of OX40 and 4-1BB heterodimer in activated human T cells. Blood 2005;106:2002-2010.